The Authenticity Imperative: How Indian Pharmaceutical Manufacturers Are Leading the Fight Against Counterfeit Drugs in the American Supply Chain
Counterfeit medications represent one of the most serious and underreported threats to American patient safety, with falsified drugs estimated to cost the US healthcare system billions of dollars annually while putting lives at risk. Indian pharmaceutical manufacturers, as major contributors to the American generic drug supply, are deploying sophisticated anti-counterfeiting technologies that may prove to be the most effective defense the market has yet seen.